Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Stutz

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Trends in Microbiology|August 19, 2018
Mycobacterium tuberculosis: prePPARing and Maintaining the Replicative NicheMichael D Stutz, Marc Pellegrini
Frontiers in Immunology|June 13, 2018
Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for <i>Mycobacterium tuberculosis</i> Infection?Michael D Stutz, Samar Ojaimi, Gregor Ebert, et al.
Journal of Leukocyte Biology|January 19, 2018
Mycobacterium tuberculosis: Rewiring host cell signaling to promote infectionMichael D Stutz, Michelle P Clark, Marcel Doerflinger, et al.
The Journal of Cell Biology|December 12, 2012
Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cellsDimitri Conomos, Michael D Stutz, Mark Hills, et al.
Nucleic Acids Research|November 15, 2013
Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processesMichael Lee, Mark Hills, Dimitri Conomos, et al.
Plos Genetics|June 9, 2015
A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of TelomeraseAnagha Killedar, Michael D Stutz, Alexander P Sobinoff, et al.
Immunology and Cell Biology|August 15, 2018
Constitutive overexpression of TNF in BPSM1 mice causes iBALT and bone marrow nodular lymphocytic hyperplasiaCyril Seillet, Elyas H Arvell, Derek Lacey, et al.
Cell Death and Differentiation|December 13, 2017
Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restrictedMichael D Stutz, Samar Ojaimi, Cody Allison, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosisGregor Ebert, Cody Allison, Simon Preston, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Trends in Microbiology|August 19, 2018
Mycobacterium tuberculosis: prePPARing and Maintaining the Replicative NicheMichael D Stutz, Marc Pellegrini
Frontiers in Immunology|June 13, 2018
Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for <i>Mycobacterium tuberculosis</i> Infection?Michael D Stutz, Samar Ojaimi, Gregor Ebert, et al.
Journal of Leukocyte Biology|January 19, 2018
Mycobacterium tuberculosis: Rewiring host cell signaling to promote infectionMichael D Stutz, Michelle P Clark, Marcel Doerflinger, et al.
The Journal of Cell Biology|December 12, 2012
Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cellsDimitri Conomos, Michael D Stutz, Mark Hills, et al.
Nucleic Acids Research|November 15, 2013
Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processesMichael Lee, Mark Hills, Dimitri Conomos, et al.
Plos Genetics|June 9, 2015
A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of TelomeraseAnagha Killedar, Michael D Stutz, Alexander P Sobinoff, et al.
Immunology and Cell Biology|August 15, 2018
Constitutive overexpression of TNF in BPSM1 mice causes iBALT and bone marrow nodular lymphocytic hyperplasiaCyril Seillet, Elyas H Arvell, Derek Lacey, et al.
Cell Death and Differentiation|December 13, 2017
Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restrictedMichael D Stutz, Samar Ojaimi, Cody Allison, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosisGregor Ebert, Cody Allison, Simon Preston, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.
Pageof 2